 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                    
                                        Comment: Homodimeric endogenous peptide ligand consisting of two subunits chains of inhibin βA. Interacts with activin type I and II receptors.
                                    
                                 
                                    Species: Human
                                 | 
| References | 
| 1. Sun J, Tam L-TT, Han H-Q, Kwak KS-N, Zhou X, Lu J. (2013) Variant activin receptor polypeptides and uses thereof. Patent number: US8501678 B2. Assignee: Atara Biotherapeutics, Inc.. Priority date: 06/03/2007. Publication date: 06/08/2013. | 
| 2. Suragani RN, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, Davies MV, Alexander MJ, Devine M, Loveday KS et al.. (2014) Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med, 20 (4): 408-14. [PMID:24658078] |